Concord Asset Management (Virginia)’s Vertex Pharmaceuticals VRTX Stock Holding History

Concord Asset Management (Virginia)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$1.66M	Sell
2024 Q4	$1.44M	Buy
2024 Q3	$1.31M	Buy
2024 Q2	$1.09M	Buy
2024 Q1	$649K	Buy
2023 Q4	$466K	Buy
2023 Q3	$230K	Buy